Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism
Open Access
- 28 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 2 (4), e152
- https://doi.org/10.1038/cddis.2011.36
Abstract
Gemcitabine (GEM, 2′,2′-difluorodeoxycytidine) is currently used in advanced pancreatic adenocarcinoma, with a response rate of < 20%. The purpose of our work was to improve GEM activity by addition of cannabinoids. Here, we show that GEM induces both cannabinoid receptor-1 (CB1) and cannabinoid receptor-2 (CB2) receptors by an NF-κB-dependent mechanism and that its association with cannabinoids synergistically inhibits pancreatic adenocarcinoma cell growth and increases reactive oxygen species (ROS) induced by single treatments. The antiproliferative synergism is prevented by the radical scavenger N-acetyl-L-cysteine and by the specific NF-κB inhibitor BAY 11-7085, demonstrating that the induction of ROS by GEM/cannabinoids and of NF-κB by GEM is required for this effect. In addition, we report that neither apoptotic nor cytostatic mechanisms are responsible for the synergistic cell growth inhibition, which is strictly associated with the enhancement of endoplasmic reticulum stress and autophagic cell death. Noteworthy, the antiproliferative synergism is stronger in GEM-resistant pancreatic cancer cell lines compared with GEM-sensitive pancreatic cancer cell lines. The combined treatment strongly inhibits growth of human pancreatic tumor cells xenografted in nude mice without apparent toxic effects. These findings support a key role of the ROS-dependent activation of an autophagic program in the synergistic growth inhibition induced by GEM/cannabinoid combination in human pancreatic cancer cells.Keywords
This publication has 42 references indexed in Scilit:
- The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiationInternational Journal of Oncology, 2010
- The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5JCI Insight, 2009
- Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Intracellular zinc increase inhibits p53−/− pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Involvement of Selective Reactive Oxygen Species Upstream of Proapoptotic Branches of Unfolded Protein ResponseOnline Journal of Public Health Informatics, 2008
- Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinomaCancer Gene Therapy, 2007
- Analysis of Promoter Regions Regulating Basal and Interleukin-4-Inducible Expression of the Human CB1 Receptor Gene in T LymphocytesMolecular Pharmacology, 2007
- That which does not kill me makes me stronger: adapting to chronic ER stressTrends in Biochemical Sciences, 2007
- Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic EffectsMolecular Pharmacology, 2007
- A new strategy to block tumor growth by inhibiting endocannabinoid inactivationThe FASEB Journal, 2004